Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 19
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Immunocore Holdings PLC
IMCR
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$29.40
-0.08
-0.27%
Ult. Agg.: Oct 16, 4:00 PM
$29.40
-0.08
-0.27%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Immunocore Holdings Financials
Immunocore Holdings (IMCR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Immunocore Hldgs Q2 EPS $(0.02) Misses $0.02 Estimate, Sales $115.927M Beat $110.374M Estimate
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.02 by 200 percent. This is a 90 percent increase over losses of $(0.20) per share from the
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
Immunocore Hldgs Q1 EPS $0.25 Beats $(0.25) Estimate, Sales $106.677M Miss $107.731M Estimate
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(0.25) by 200 percent. This is a 150 percent increase over earnings of $0.10 per share from the
Benzinga Newsdesk
Immunocore Holdings Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Immunocore Hldgs Q4 EPS $(0.60) Misses $(0.23) Estimate, Sales $104.478M Miss $107.310M Estimate
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.23) by 164.32 percent. This is a 27.66 percent decrease over losses of $(0.47) per share
Benzinga Newsdesk
Earnings Scheduled For February 25, 2026
Benzinga Insights
